Wen‐Yu Su
Impact in
- Molecular Medicine top 2%
- Hydrogels: synthesis, properties, applications
- Biomaterials top 2%
- Electrospun Nanofibers in Biomedical Applications
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 3
- Surgery 9
- Co-authors
- Feng‐Huei Lin (8 shared papers)Yu‐Chun Chen (4 shared papers)Jen Ming Yang (3 shared papers)Ming Yang (1 shared paper)Ching‐Li Tseng (3 shared papers)Kai‐Chiang Yang (2 shared papers)Ko-Chung Yen (1 shared paper)Shuhua Yang (2 shared papers)
- Journals
- Journal of Cellular and Molecular Medicine (3 papers)Acta Biomaterialia (2 papers)Oncotarget (2 papers)European Journal of Medicinal Chemistry (2 papers)Analytical Chemistry (2 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Wen‐Yu Su
45 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 128
- Molecular Medicine 235
- Biomaterials 512
- Pharmaceutical Science 151
- Pathology and Forensic Medicine 178
- Rehabilitation 66
Countries citing papers authored by Wen‐Yu Su
This map shows the geographic impact of Wen‐Yu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Yu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Yu Su more than expected).
Fields of papers citing papers by Wen‐Yu Su
This network shows the impact of papers produced by Wen‐Yu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Yu Su. The network helps show where Wen‐Yu Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Wen‐Yu Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 295 | |
| 2 | 2010 | 209 | |
| 3 | 2009 | 207 | |
| 4 | 2009 | 103 | |
| 5 | 2011 | 97 | |
| 6 | 2012 | 94 | |
| 7 | 2011 | 87 | |
| 8 | 2011 | 79 | |
| 9 | 2013 | 54 | |
| 10 | 2005 | 53 | |
| 11 | 2021 | 46 | |
| 12 | 2009 | 43 | |
| 13 | 2022 | 43 | |
| 14 | 2023 | 42 | |
| 15 | 2017 | 38 | |
| 16 | 2021 | 33 | |
| 17 | 2011 | 29 | |
| 18 | 2002 | 23 | |
| 19 | 2016 | 22 | |
| 20 | 2022 | 17 |
About Wen‐Yu Su
Wen‐Yu Su is a scholar working on Molecular Biology, Surgery, Biomedical Engineering, Infectious Diseases and Oncology, having authored 47 papers that have together received 1.8k indexed citations. Recurring topics across this work include Bone Tissue Engineering Materials (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Advanced Drug Delivery Systems (4 papers), RNA Interference and Gene Delivery (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Sepsis Diagnosis and Treatment (3 papers) and Animal Virus Infections Studies (2 papers). The work is most often cited by research in Molecular Medicine (235 citations), Biomaterials (512 citations), Pharmaceutical Science (151 citations), Pathology and Forensic Medicine (178 citations) and Rehabilitation (66 citations). Wen‐Yu Su has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Feng‐Huei Lin, Yu‐Chun Chen, Jen Ming Yang, Ming Yang, Ching‐Li Tseng, Kai‐Chiang Yang, Ko-Chung Yen, Shuhua Yang, Jing‐Yuan Fang and Hua Xiong. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Acta Biomaterialia, Oncotarget, European Journal of Medicinal Chemistry and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.